High levels of factor IX increase the risk of venous thrombosis

Blood

Volumn 95, Issue 12, 2000, Pages 3678-3682

  Van Hylckama Vlieg, Astrid ^a   Van Der Linden, Irma K ^a   Bertina, Rogier M ^a   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0034660655     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3678     Document Type: Article

References (33)

1. Nordström M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-160.
2. Anderson FA, Wheeler HB. Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
3. Miletich JP, Prescott SM, White R, et al. Inherited predisposition to thrombosis. Cell. 1993;72: 477-480.
4. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part 1. Thromb Haemost. 1996;76:651-662.
5. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167-1173.
6. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost. 1997;78:297-301.
7. Carter CJ. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis. 1994;36:423-438.
8. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-530.
9. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370-1373.
10. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984;74: 2082-2088.
11. Bertina RM. Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature. 1994; 369:64-67.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
13. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 1997;43:1678-1683.
14. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-155.
15. Falcon CR, Cattaneo M, Panzeri D, et al. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-1083.
16. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.
17. Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696-701.
18. de Visser MCH, Poort SR, Vos HL, et al. Factor X promoter polymorphisms, factor X levels and the risk of venous thrombosis [abstract]. Thomb Haemost. 1999(suppl):508.
19. Furie B, Furie BC. The molecular basis of blood coagulation. Cell. 1988;53:505-518.
20. van Dieijen G, Tans G, Rosing J, Hemker C. The role of phospholipid and factor Villa in the activation of bovine factor X. J Biol Chem. 1981;256: 3433-3442.
21. Reiner AP, Davie EW. The physiology and biochemistry of factor IX. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis. 3rd ed. Edinburgh: Churchill Livingstone. 1994;309-324.
22. Simpson NE, Biggs R. The inheritance of Christmas factor. Br J Haematol. 1962;8:191-203.
23. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97:775-784.
24. Sweeney JD, Hoernig LA. Age-dependent effect on the level of factor IX. Am J Clin Pathol. 1993; 99:687-688.
25. Briët E, van Tilburg NH, Veltkamp JJ. Oral contraception and the detection of carriers in haemophilia B. Thromb Res. 1978;13:379-388.
26. van der Meer FJ, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997;78:631-635.
27. KosterT, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-1506.
28. Poort SR, van der Linden IK, Krommenhoek-van Es C, et al. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays. Thomb Haemost. 1986;55:122-128.
29. Koster T, Rosendaal FR, Reitsma PH, et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb Haemost. 1994;71: 719-722.
30. Vandenbroucke JP, Koster T, Briët E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994;344:1453-1457.
31. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, et al. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Thromb Haemost. 1998;80:382-387.
32. Koster T, Briët E, van der Meer FJ, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85:2756-2761.
33. Rosendaal FR. Thrombosis in the young: epidemiology and risk factors: a focus on venous thrombosis. Thromb Haemost. 1997;78:1-6.